Literature DB >> 1698934

Misperceptions of comprehension difficulties of stroke patients by doctors, nurses and relatives.

R McClenahan1, M Johnston, Y Densham.   

Abstract

Doctors, nurses and relatives involved with 30 recently aphasic stroke patients were asked to predict how the patient would perform on a comprehension test. Results show that not only do doctors, nurses and relatives underestimate the receptive disability of these patients, but they also illustrate a lack of agreement between health professionals. Implications for management are considered.

Entities:  

Mesh:

Year:  1990        PMID: 1698934      PMCID: PMC488177          DOI: 10.1136/jnnp.53.8.700

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Aphasia after stroke: natural history and associated deficits.

Authors:  D T Wade; R L Hewer; R M David; P M Enderby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

2.  The aphasia quotient: the taxonomic approach to measurement of aphasic disability.

Authors:  A Kertesz; E Poole
Journal:  Can J Neurol Sci       Date:  1974-02       Impact factor: 2.104

3.  Behavioural assessments of physically disabled patients: agreement between rehabilitation therapists and nurses.

Authors:  M Johnston; I Bromley; M Boothroyd-Brooks; W Dobbs; A Ilson; K Ridout
Journal:  Int J Rehabil Res       Date:  1987       Impact factor: 1.479

4.  Reliability and validity characteristics of the Western Aphasia Battery (WAB).

Authors:  C M Shewan; A Kertesz
Journal:  J Speech Hear Disord       Date:  1980-08

5.  Spouses' understanding of the communication disabilities of aphasic patients.

Authors:  J W Helmick; T S Watamori; J M Palmer
Journal:  J Speech Hear Disord       Date:  1976-05
  5 in total
  1 in total

1.  APHASIA: Not Yet at the High Table [In the Comity of Neurology Sub-Specialities].

Authors:  Apoorva Pauranik
Journal:  Ann Indian Acad Neurol       Date:  2020-09-25       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.